Khaberni - Surgeons in China succeeded in transplanting a part of a genetically modified pig liver to a patient suffering from liver cancer and advanced cirrhosis, in a medical step described by experts as historic.
The liver functioned effectively for a temporary period after the removal of the right lobe of the diseased liver, which was afflicted with a tumor the size of a grapefruit. A part of the pig liver was transplanted onto the left lobe, where the transplanted liver worked to secrete bile and produce blood clotting factors, and the body did not initially reject the transplant.
After 38 days, the transplanted liver section was removed due to medical complications, and the patient died after five and a half months, as he was not eligible to receive a human liver due to his advanced disease.
A step that opens promising horizons, experts believe this experiment marks the beginning of a new era in organ transplantation, and this technique could help bridge the shortage of human organs and provide new opportunities for patients suffering from critical illnesses.
